KEYVANTAGE WEALTH, LLC

Position in JNJ — Johnson & Johnson

CIK 2050555 BETHLEHEM, PA

Position in JNJ

as of Jun 30, 2026 · filed Aug 11, 2026 Compact

Position Value

$1,058,292

-$12,110 QoQ

Shares Held

4,167

-4.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

1.83%

of 13F equity value

Holder Rank

#2,974

of 4,676 holders

Holding Since

Dec 2024

7 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

KEYVANTAGE WEALTH, LLC holds $3,559,634 across 5 Drug Manufacturers - General names. JNJ ranks #1 (29.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson This page	4,167	$1,058,292
2	LLY	ELI LILLY & Co	594	$712,461
3	GILD	Gilead Sciences, Inc.	5,453	$688,932
4	MRK	Merck & Co., Inc.	4,857	$624,124
5	AMGN	Amgen Inc	1,314	$475,825

7 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,058,292	4,167	-4.8%	Shares	Sole	2026-08-11
2026-03-31	$1,070,402	4,379	+10.2%	Shares	Sole	2026-05-05
2025-12-31	$822,005	3,972	+13.2%	Shares	Sole	2026-02-10
2025-09-30	$650,824	3,510	-1.4%	Shares	Sole	2025-11-07
2025-06-30	$543,790	3,560	-14.3%	Shares	Sole	2025-08-08
2025-03-31	$688,899	4,154	+21.0%	Shares	Sole	2025-05-07
2024-12-31	$496,480	3,433	—	Shares	Sole	2025-02-14
No filing history on record for this holder in this stock.